Cardio Diagnostics, a precision medtech company is transforming the prevention of cardiovascular disease (CVD) by developing the first at-home clinical […]
Traditionally, medicine has followed a one-drug-for-all patients approach to disease, largely as a result of our poor understanding of pharmacology […]
We live in a world that is being run by data, an immense amount of data. Today, we can collect […]
Earlier this week, Stephane Budel wrote an article about the role diagnostic technologies will play in the future of precision medicine. […]
Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]
Cancer Research UK (CRUK) has funded a project run by a team of researchers at the University of Bristol to […]
Singapore’s Health Sciences Authority has authorised clinical use of a new test for SARS-CoV-2 according to the Agency for Science, Technology, and Research (A*STAR).
Researchers hope that the effort will be able to validate liquid biopsy (LB) diagnostic methods for childhood lymphomas that are endemic in the region
Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.
FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]